Fortis Healthcare revises London investor meet schedule for Sept 14-15

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • Fortis Healthcare revised its London investor meet intimation for September 14-15, 2026
  • The non-deal roadshow organized by Jefferies will now feature group meetings instead of one-on-one sessions
  • Management from both Fortis Healthcare and IHH Healthcare Berhad will participate in the discussions
  • The disclosure was filed under Regulation 30 of SEBI LODR Regulations on September 9, 2026
powered bylight_fuzz_icon
50512527

*this image is generated using AI for illustrative purposes only.

Fortis Healthcare Limited has issued a revised intimation for its non-deal roadshow in London on September 14 and 15, 2026. The company clarified that the meetings will be conducted in a group format rather than one-on-one sessions.

The disclosure, filed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, updates a previous filing made earlier on September 9, 2026. The event is organized by Jefferies and involves discussions with the management of both Fortis Healthcare Limited and IHH Healthcare Berhad.

Meeting Details

Date & Time Event Mode Type Location
Sept 14-15, 2026 Non-deal roadshow In-person Group Meet London

The meetings are scheduled from 8 am to 5 pm BST (12:30 pm to 9:30 pm IST). The agenda includes general business updates and industry discussions.

Satyendra Chauhan, Company Secretary and Compliance Officer, signed the revised disclosure. The company confirmed that no unpublished price-sensitive information will be shared during the interactions.

Schedules remain subject to change based on investor or company exigencies.

Historical Stock Returns for Fortis Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
+1.98%-5.22%-13.91%-3.59%-26.07%+179.60%

How might the shift to group-format meetings influence the depth of engagement with institutional investors compared to previous one-on-one sessions?

What strategic synergies or operational updates regarding the Fortis-IHH partnership are investors likely to prioritize during these London discussions?

Could this non-deal roadshow signal upcoming capital raising activities or strategic restructuring plans for Fortis Healthcare in the near future?

Fortis Healthcare may move Supreme Court against Delhi HC order in Daiichi arbitration case

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Fortis Healthcare is reportedly considering filing an appeal in the Supreme Court against a Delhi High Court order
  • The legal matter pertains to the Daiichi arbitration case
  • The development was reported by a newspaper and remains unconfirmed by the company
powered bylight_fuzz_icon
49866353

*this image is generated using AI for illustrative purposes only.

Fortis Healthcare is reportedly considering approaching the Supreme Court to challenge a Delhi High Court order in connection with the Daiichi arbitration case, according to a newspaper report.

Background on the legal development

The report indicates that Fortis Healthcare may escalate the legal dispute to the Supreme Court following the Delhi High Court's order in the Daiichi arbitration matter. The development signals a potential continuation of legal proceedings at the highest judicial level in India.

Parameter Details
Company Fortis Healthcare
Legal action reported May move Supreme Court
Against Delhi High Court order
Case Daiichi arbitration
Source Newspaper report

Key considerations

  • The reported move involves challenging a Delhi High Court order related to the Daiichi arbitration case.
  • The development is sourced from a newspaper report and has not been independently confirmed.
  • The matter, if pursued, would be heard at the Supreme Court of India.

Historical Stock Returns for Fortis Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
+1.98%-5.22%-13.91%-3.59%-26.07%+179.60%
Disclaimer: This article is AI-generated using data from LiveSquawk. ScanX is not liable for any inaccuracies.

How might a Supreme Court ruling in the Daiichi arbitration case impact Fortis Healthcare's valuation and investor confidence?

What are the potential financial liabilities or settlement costs Fortis could face if the Supreme Court upholds the Delhi High Court's order?

Could this prolonged legal battle distract management from core operational growth and expansion strategies in the healthcare sector?

More News on Fortis Healthcare

1 Year Returns:-26.07%